Back Stocks profile

Stock analysis tool for investors

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE:532488

₹4790.60 243.60 (5.36%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

4563.80

Today’s High

4810.00

52W low

3295.30

52W High

4810.00

Open Price

4571.00

Prev. Close

4448.9000

Volume

1311648.00

Value

6283580908.80

Fundamentals

Market Cap

127175.40

Price to Earnings

79.50

Price to Book Value

9.40

Dividend Yield

0.60

PE to Growth

-6.50

Op Revenue TTM

7845.00

Net Profit TTM

1600.00

Cash From Operating Activity

1261.00

Return on Equity %

11.78

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

26 Jul, 2024

46.9

Week

50.3

Month

57.8

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

4721.48

PIVOT

First Resistance

4879.12

Second Resistance

4967.63

Third Resistance

5125.27

First Support

4632.97

Second Support

4475.33

Third Support

4386.82

Relative Strength Index

68.31

Money Flow Index

50.39

MACD

46.82

MACD Signal

46.08

Average True Range

113.97

Average Directional Index

17.67

Rate of Change (21)

5.4

Rate of Change (125)

32.51

Commodity Channel Index

289.4

Williams %R

-4.7

BETA

1 Month

1.33

3 Month

0.37

1 Year

0.5

3 Year

0.14

PRICE CHANGE ANALYSIS

5.99%

1 Week

Low

High

4395.3

4810

5.4%

1 Month

Low

High

4395.3

4810

19.28%

3 Months

Low

High

3724

4810

33.86%

6 Months

Low

High

3350

4810

30.16%

1 Year

Low

High

3295.3

4810

Bigul
25 Jul 2024

DIVI'S LABORATORIES LTD. - 532488 - Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter Ended June 30, 2024.

DIVI''s LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/08/2024 ,inter alia, to consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter ended June 30, 2024.
Bigul
20 Jul 2024

Divis Labs: What should investors do?

The stock trades above its premium valuation anticipating strong growth
Bigul
17 Jul 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper publication regarding 34th AGM, E-voting and other information.
Bigul
15 Jul 2024

DIVI'S LABORATORIES LTD. - 532488 - Business Responsibility and Sustainability Reporting (BRSR)

Business Responsibility and Sustainability Report for the financial year ended March 31, 2024.
Bigul
15 Jul 2024

DIVI'S LABORATORIES LTD. - 532488 - Reg. 34 (1) Annual Report.

The 34th Annual General Meeting (AGM) of the Company is scheduled to be held on Monday, August 12, 2024 at 10.00 a.m. IST through Video Conferencing (VC) / Other Audio-Visual Means (OAVM). Pursuant to Regulation 34 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed Notice convening the 34th AGM of the Company and Annual Report for the financial year 2023-24, being sent to the members through electronic mode. The Annual Report 2023-24 containing the Notice of the 34th AGM is also uploaded on the Company's website at https://www.divislabs.com/investor-relations/reports-and-filings/annual-reporting/.
Bigul
13 Jul 2024

DIVI'S LABORATORIES LTD. - 532488 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Newspaper Clippings related to notice to shareholders regarding 34th Annual General Meeting, Record date for dividend and other information
Bigul
29 Jun 2024

DIVI'S LABORATORIES LTD. - 532488 - Closure of Trading Window

Intimation of Trading Window closure from July 01, 2024 till 48 hours after the declaration of unaudited financial results of the Company for the quarter ending June 30, 2024.
See all News

FAQs

The latest market price of Divi's Laboratories Ltd. on NSE was Rs. 4790.60 as of today.

The opening share price of Divi's Laboratories Ltd. was Rs. 4571.00 as of today.

The 52-week high share price of Divi's Laboratories Ltd. was Rs. 4810.00.

The 52 week low share price of Divi's Laboratories Ltd. was Rs. 3295.30.

Please find Corporate actions section for more details.

The PE ratio of Divi's Laboratories Ltd. is -6.50. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Divi's Laboratories Ltd. was on 2024-08-02 for Rs. 30 per share. According to today’s share price, the dividend yield of Divi's Laboratories Ltd. stands at 0.60. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Divi's Laboratories Ltd. was as of 2015-09-23. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Divi's Laboratories Ltd. was as of 2007-08-03. The split ratio declared in this issue was 10:2. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Divi's Laboratories Ltd..

Close

Let's Open Free Demat Account